The most common primary malignant bone tumor, osteosarcoma, typically occurs in adolescents and young adults. Patients with localized osteosarcoma at presentation have a 60~80% rate of long-term survival. But carriers of a p53 germline mutation, Li-Fraumeni syndrome (LFS), have a life-time risk of 90% of developing a malignancy. 1) LFS, which was first described in 1969 by Li and Fraumeni, is a cancer predisposition syndrome associated with sarcoma and wide spectrum of tumors. 2) Here, we report a p53 germline mutation in a 17-year-old girl LFS patient with osteosarcoma in proximal tibia and adenocarcinoma of lung.
. Plain radiographs showed the 4 cm sized eccentric bonedestructive lesion with permiative pattern on right proximal tibia and the Codman's triangle on lateral cortex. tomography of chest and abdomen, whole body bone scan and positron emission tomography-computed tomography (PET-CT).
And, we discovered 2 cm sized nodular lesion with contrast enhancement in right upper medial breast and several small peripheral uncharacterized nodules in left lower lobe and right lower lobe of lung on enhanced chest CT ( Fig. 3 ) and same lesions on PET-CT (Fig. 4 ).
The patient referred to pediatric oncology department for preoperative chemotherapy. Then, excisional biopsy about the right breast nodule and video-assisted thoracoscopic operation about the right lower lobe nodule were performed. The right breast nodule was histopathologically confirmed to benign fibro-epithelial lesion, but the nodule of the right lung lower lobe was confirmed to adenocarcinoma in situ (bronchiole-alveolar carcinoma).
Through review of her family history revealed multiple early onset cancer, including colon cancer, gastric cancer, neuroendocrine cancer and breast cancer ( Fig. 5 ). Her father has been diagnosed with gastric cancer at 40 years old and neuroendocrine cancer at 45 years old. And two uncles were died because of the colon cancer Post-operative 2 years, there is no radiologic abnormality change of the implant such as aseptic loosening etc. (Fig. 6 ).
Discussion
Li-Fraumeni syndrome (LFS) was described in 1969 by Li and In other words, LFS is classified into two major subgroup: classic LFS and LFL syndrome, which share some, but not all, of the features of LFS. 3) Classic LFS was based on 24 families. 4) The classical definition of the LFS is based on the following three parameters: (1) a proband with a sarcoma diagnosed before the age of 45; (2) a first degree relative with cancer before the age of 45; and (3) another first or second degree relative with either a sarcoma diagnosed at any age or any cancer diagnosed under the age of 45. Although sarcomas are quite frequently observed LFS, a broad range of other tumors may occur including breast cancer, brain tumors, lung cancer, larynger cancer, leukemia, adrenal cortical neoplasia, and others. Furthermore, more relaxed criteria were released for variations of a LFL syndrome. 5, 6) More inclusive clinical classification schemes were described by Birch and Eeles 7) in 1995 to 1996, which characterized LFS but that did not fulfill the strict definition. 7, 8) The classic LFS, Like this patient, osteosarcoma has been well characterized as one of the tumors known to occur in LFS, the cancer predisposition syndrome resulting from germline mutations in TP53. The TP53 protein functions mainly as a transcription factor, and is important for normal cell growth, apoptosis, and DNS repair. The TP53 gene has been observed to undergo somatic mutation in tumors, many of which disrupt the DNA-binding domain, and result in a loss of tumor suppressor function, leading to a more aggressive tumor phenotype. 9, 10) Like LFS the identification of at-risk family members by predictive testing is often recommended as enhanced surveillance for early diagnosis and prevention of disease is a critical part of primary care.
Also, the risk of developing secondary, radiating-induced malignancies was described as elevated in LFS patients, since the first reports of LFS by Li and Fraumeni. 1) So exposure should be as low as possible, although a general contraindication for any type of radiological diagnostic or treatment cannot be started.
In conclusion, LFS is a hereditary cancer syndrome characterized by a high risk of developing various types of cancer from birth through late adulthood, often at younger ages than normally expected. And most of the core cancers of LFS area associated with a poor prognosis, so it is important to have regular check-ups and cancer screening test. In other words, cancer screening examinations are medical tests performed when a person has no symptoms. Likewise, if you find a tumor in young patients we should always keep in mind familial cancer syndrome like LFS.
